Skip to content

Savara SVRA Total Operating Expenses

Total Operating Expenses at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$37.68M+18.2%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$27.18M-8.9%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$12.32M+19.3%
TRV
Trevi Therapeutics, Inc.TRVI
$14.91M+30.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$116.31M+23.8%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's total operating expenses?
Savara (SVRA) reported total operating expenses of $38.99M in Q1 2026.
How has Savara's total operating expenses changed year-over-year?
Savara's total operating expenses increased by 37.1% year-over-year, from $28.44M to $38.99M.
What is the long-term trend for Savara's total operating expenses?
Over 4 years (2021 to 2025), Savara's total operating expenses has grown at a 31.4% compound annual growth rate (CAGR), from $41.48M to $123.55M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.